- All sections
- G - Physics
- G16B - Bioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology
- G16B 15/30 - Drug targeting using structural dataDocking or binding prediction
Patent holdings for IPC class G16B 15/30
Total number of patents in this class: 827
10-year publication summary
|
8
|
4
|
8
|
41
|
39
|
65
|
123
|
173
|
150
|
146
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Genentech, Inc. | 3976 |
26 |
| NEC Laboratories America, Inc. | 1147 |
21 |
| Pythia Labs, Inc. | 14 |
14 |
| DeepMind Technologies Limited | 420 |
12 |
| Tencent Technology (Shenzhen) Company Limited | 14747 |
9 |
| Flagship Pioneering Innovations VI, LLC. | 456 |
9 |
| FUJIFILM Corporation | 29367 |
8 |
| The Board of Trustees of the Leland Stanford Junior University | 6408 |
8 |
| Regeneron Pharmaceuticals, Inc. | 4264 |
8 |
| X Development LLC | 1302 |
8 |
| The Broad Institute, Inc. | 1808 |
7 |
| Ecole Polytechnique Federale de Lausanne (epfl) | 1535 |
7 |
| Cyclica Inc. | 13 |
7 |
| Benevolentai Technology Limited | 63 |
7 |
| International Business Machines Corporation | 61228 |
6 |
| Centre National de La Recherche Scientifique | 10418 |
6 |
| Fujitsu Limited | 18351 |
6 |
| Massachusetts Institute of Technology | 10057 |
6 |
| Innoplexus AG | 130 |
6 |
| Deargen Inc. | 26 |
6 |
| Other owners | 640 |